Posts in tag

S3


The TGA is calling for comments from interested parties on its review of reforms to advertising of pharmacist-only medicines A recent review of the Scheduling Policy Framework resulted in proposed …

New research by UTS involving more than 2000 participants has shown S3 advertising is unlikely to lead to inappropriate use of medicine The Australian Self Medication Industry (ASMI) commissioned the …

A widespread switch from prescription to OTC medicines is best for the healthcare system and consumers, says ASMI in its 2017 pre-budget submission The Australian Self-Medication Industry, which released its …

More work needs to be done on downscheduling medicines in Australia, the Minister for Health believes. Meanwhile a final decision on the scheduling of codiene could be delivered before the …

ASMI is disappointed with the Government’s decision to retain S3 advertising restrictions and to replace  the current mandatory advertising pre-approvals system with a self-regulatory system, it says. In welcoming the …

Pharmacies have an edge in skin care that virtually no other retailer can boast: the presence of Pharmacy-Only and Pharmacist-Only products that draw customers into the community pharmacy sector. And …

It’s time to get serious about direct-to-consumer advertising of S3 products, ortherwise known as Pharmacist Only medications, says Dr Deon Schoombie.

Momentum is building for reform of the switch environment and Schedule 3 advertising policy, said presenters and participants at ASMI’s annual conference yesterday. ASMI Chief Executive Officer, Deon Schoombie, said: …

Today at its annual conference in Sydney the Australian Self Medication Industry shared a ‘sample mock ad’, which demonstrated the proposed consumer communication model it has been advocating for Schedule …

Pain management best practice can be improved with the help of pharmacy staff in S3 referrals as they are often the first point of contact with customers who present with strong …

Many pharmacists are taking Schedule 3 medicines for granted, writes Phil Spyrou… which could end up costing the profession dearly. Pharmacists across Australia are looking to expand the scope of …

ASMI says that the Expert Panel report on the regulatory framework for medicines and medical devices falls short in its recommendation to retain restrictions on the advertising of S3 medicines. …